| Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries KS Louie, S De Sanjose, M Diaz, X Castellsagué, R Herrero, CJ Meijer, ... British journal of cancer 100 (7), 1191-1197, 2009 | 420 | 2009 |
| Epidemiology and prevention of human papillomavirus and cervical cancer in sub‐Saharan Africa: a comprehensive review KS Louie, S De Sanjose, P Mayaud Tropical Medicine & International Health 14 (10), 1287-1302, 2009 | 324 | 2009 |
| HPV and cerival cancer in the world: 2007 report. X Castellsague, S De Sanjose, T Aguado, KS Louie, L Bruni, J Muñoz, ... | 293 | 2007 |
| Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis KS Louie, A Seigneurin, P Cathcart, P Sasieni Annals of Oncology 26 (5), 848-864, 2015 | 233 | 2015 |
| Influence of cannabis use on severity of hepatitis C disease JH Ishida, MG Peters, C Jin, K Louie, V Tan, P Bacchetti, NA Terrault Clinical gastroenterology and hepatology 6 (1), 69-75, 2008 | 184 | 2008 |
| Trends in head and neck cancers in England from 1995 to 2011 and projections up to 2025 KS Louie, H Mehanna, P Sasieni Oral oncology 51 (4), 341-348, 2015 | 145 | 2015 |
| Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam EJ Domingo, R Noviani, MRM Noor, CA Ngelangel, KK Limpaphayom, ... Vaccine 26, M71-M79, 2008 | 141 | 2008 |
| Smoking and passive smoking in cervical cancer risk: pooled analysis of couples from the IARC multicentric case–control studies KS Louie, X Castellsague, S de Sanjose, R Herrero, CJ Meijer, K Shah, ... Cancer epidemiology, biomarkers & prevention 20 (7), 1379-1390, 2011 | 131 | 2011 |
| Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review KS Louie, JM Micallef, JM Pimenta, UM Forssen Journal of viral hepatitis 18 (1), 1-7, 2011 | 121 | 2011 |
| The high comorbidity burden of the hepatitis C virus infected population in the United States KS Louie, S St Laurent, UM Forssen, LM Mundy, JM Pimenta BMC infectious diseases 12, 1-11, 2012 | 118 | 2012 |
| Human papillomavirus (HPV) vaccine effectiveness and potential herd immunity for reducing oncogenic oropharyngeal HPV-16 prevalence in the United Kingdom: a cross-sectional study H Mehanna, TS Bryant, J Babrah, K Louie, JL Bryant, RJ Spruce, N Batis, ... Clinical Infectious Diseases 69 (8), 1296-1302, 2019 | 47 | 2019 |
| Effect of HPV vaccination and cervical cancer screening in England by ethnicity: a modelling study HC Johnson, EI Lafferty, RM Eggo, K Louie, K Soldan, J Waller, ... The lancet Public health 3 (1), e44-e51, 2018 | 46 | 2018 |
| Awareness of the link between human papillomavirus and oral cancer in UK university students RH Dodd, M Freeman, F Dekaj, J Bamforth, A Miah, P Sasieni, KS Louie Preventive Medicine 150, 106660, 2021 | 38 | 2021 |
| Perception about barriers and facilitators of the school-based HPV vaccine program of Manizales, Colombia: A qualitative study in school-enrolled girls and their parents V Cordoba-Sanchez, OL Tovar-Aguirre, S Franco, NEA Ortiz, K Louie, ... Preventive medicine reports 16, 100977, 2019 | 25 | 2019 |
| Real-world use of talimogene laherparepvec in German patients with stage IIIB to IVM1a melanoma: a retrospective chart review and physician survey P Mohr, S Haferkamp, A Pinter, C Weishaupt, MA Huber, G Downey, ... Advances in therapy 36, 101-117, 2019 | 21 | 2019 |
| Papillomavirus humains (HPV) et cancers associés: aspects épidémiologiques K Louie, MN Didelot, A Damay, N Nagot, P Mayaud, M Segondy Revue francophone des laboratoires 2008 (405), 27-34, 2008 | 18 | 2008 |
| A retrospective chart review study of real-world use of talimogene laherparepvec in unresectable stage IIIB–IVM1a melanoma in four European countries ACJ van Akkooi, S Haferkamp, S Papa, V Franke, A Pinter, C Weishaupt, ... Advances in Therapy 38, 1245-1262, 2021 | 17 | 2021 |
| Access to artemisinin-combination therapy (ACT) and other anti-malarials: national policy and markets in Sierra Leone JH Amuasi, G Diap, SB Nguah, P Karikari, I Boakye, A Jambai, WK Lahai, ... PLoS One 7 (10), e47733, 2012 | 17 | 2012 |
| Access to artesunate-amodiaquine, quinine and other anti-malarials: policy and markets in Burundi JH Amuasi, G Diap, S Blay-Nguah, I Boakye, PE Karikari, B Dismas, ... Malaria journal 10, 1-9, 2011 | 17 | 2011 |
| Cinacalcet-induced hypocalcemia in a cohort of European haemodialysis patients: predictors, therapeutic approaches and outcomes KS Louie, C Erhard, DC Wheeler, P Stenvinkel, B Fouqueray, J Floege Journal of Nephrology 33, 803-816, 2020 | 15 | 2020 |
